FDA Announces Public Meeting of Oncologic Drugs Advisory Committee for Public Comment

Summary

The FDA is hosting a public meeting of the Oncologic Drugs Advisory Committee to gather input on regulatory issues, and is seeking public comments on the matter, with the meeting to be open to the public and the discussion to be documented in a public docket.